Blood versus cerebrospinal fluid: Kynurenine pathway metabolites in depression

[1]  J. P. Hamilton,et al.  Peripheral and central kynurenine pathway abnormalities in major depression , 2022, Brain, Behavior, and Immunity.

[2]  Bharathi S. Gadad,et al.  Altered levels of interleukins and neurotrophic growth factors in mood disorders and suicidality: an analysis from periphery to central nervous system , 2021, Translational Psychiatry.

[3]  J. Savitz,et al.  The Kynurenine Pathway in Traumatic Brain Injury: Implications for Psychiatric Outcomes , 2021, Biological Psychiatry.

[4]  D. Goldsmith,et al.  Associations among peripheral and central kynurenine pathway metabolites and inflammation in depression , 2020, Neuropsychopharmacology.

[5]  Henrik Zetterberg,et al.  Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau , 2019, Neurobiology of Aging.

[6]  J. Savitz.  The Kynurenine Pathway: A Finger in Every Pie , 2019, Molecular Psychiatry.

[7]  R. Perlis,et al.  Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls , 2019, Translational Psychiatry.

[8]  R. Dantzer,et al.  Serum kynurenic acid is reduced in affective psychosis , 2017, Translational Psychiatry.

[9]  D. Fuchs,et al.  An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation , 2016, Translational psychiatry.

[10]  Teresa A. Victor,et al.  Putative Neuroprotective and Neurotoxic Kynurenine Pathway Metabolites Are Associated with Hippocampal and Amygdalar Volumes in Subjects with Major Depressive Disorder , 2015, Neuropsychopharmacology.